Peter Lynch fit · Growth at a reasonable price (GARP)
Is Apellis Pharmaceuticals, Inc. (APLS) a Peter Lynch Stock?
Some GARP characteristics, but growth or valuation is stretched.
64/100
CSinais mistos
3/6 critérios atendidos
Os critérios de Peter Lynch, aplicados a APLS
PEG ≤ 1.0
chave-
EPS CAGR ≥ 15%
chave-
Revenue CAGR ≥ 10%
97.1%
Net margin > 0
2.2%
Como APLS pontua em outras estratégias
Dados financeiros ao vivo
Cap. de mercado
$5.25B
P/L (TTM)
38.8x
ROIC (TTM)
18.11%
Margem bruta
90.12%
Outras análises Peter Lynch
Perguntas frequentes
What is APLS's Peter Lynch fit score?
APLS scores 64/100 on our Peter Lynch fit engine - grade C. Some GARP characteristics, but growth or valuation is stretched.
Does Peter Lynch actually own APLS?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends APLS.
How often is this score updated?
APLS's Peter Lynch fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Ferramenta educacional, não é consultoria de investimento. As pontuações são calculadas a partir de dados financeiros públicos contra os critérios publicados de cada estratégia de investimento. Não afirmamos que Peter Lynch possua ou recomende APLS pessoalmente.